Team Members
Dr. Kleopas A. Kleopa, MD Head of Neurology Clinic, The Cyprus Institute
of Neurology and Genetics, Professor, Cyprus School of Molecular Medicine (CSMM)
Irene Sargiannidou, PhD The Cyprus Institute of Neurology and Genetics
Alexia Kagiava, PhD The Cyprus Institute of Neurology and Genetics
Marina Stavrou, PhD Student The Cyprus Institute of Neurology and Genetics
Filippos Stavropoulos, PhD Student The Cyprus Institute of Neurology and Genetics
Elena Georgiou, PhD The Cyprus Institute of Neurology and Genetics
Inherited demyelinating neuropathies are rare and disabling disorder that remain incurable. They result from mutations in genes expressed in myelinating cells of the peripheral nerves the Schwann cells. This project aims to develop genetic therapies, either gene silencing or gene replacement, specifically targeted to Schwann cells, in order to provide a therapeutic benefit in different types of demyelinating neuropathies, testing these approaches inpreclinical modelsand paving the way to clinical translation.
